Status:
COMPLETED
Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma
Lead Sponsor:
Centre of Chinese Medicine, Georgia
Collaborating Sponsors:
Rea Rehabilitation Centre, Georgia
Conditions:
Bronchial Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study was evaluation the efficacy of antiepileptic drug phenytoin (diphenine) in the treatment of bronchial asthma.
Detailed Description
Effective therapy of asthma still remains quite serious problem. According current opinion of leading specialists, asthma is an inflammatory disorder. But asthma also is a paroxysmal disorder: many sp...
Eligibility Criteria
Inclusion
- Out patients
- Bronchial asthma has been known at least for 1 year
- Absence of long-term remissions of asthma (lasting more than 1 month)
- Poorly controlled asthma, due to various reasons
- Non-smokers
Exclusion
- Presence of concomitant acute or chronic severe diseases
- Abnormal baseline haematology, blood chemistry or urinalysis
- Allergy or adverse reactions to investigational drug
- Age younger than 18 years old
- Long-term history of smoking
- Pregnancy or lactating
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00327028
Start Date
September 1 2005
End Date
December 1 2005
Last Update
February 19 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.